Sex hormones in the modulation of irritable bowel syndrome

World Journal of Gastroenterology

Volumn 20, Issue 10, 2014, Pages 2433-2448

  Mulak, Agata ^a   Taché, Yvette ^b   Larauche, Muriel ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain gut axis; Irritable bowel syndrome; Microbiota; Pain modulation; Sex hormones

Indexed keywords

ALOSETRON; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANTIBIOTIC AGENT; BETA GLUCURONIDASE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYTOCHROME P450; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUPRORELIN; MU OPIATE RECEPTOR; PAROXETINE; PREBIOTIC AGENT; PROBIOTIC AGENT; PROGESTERONE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; SEROTONIN; SEROTONIN TRANSPORTER; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TAMOXIFEN; TESTOSTERONE; THROMBOXANE; UNINDEXED DRUG; VANILLOID RECEPTOR 1;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; CHRONIC PAIN; COMORBIDITY; DRUG CLEARANCE; GENE EXPRESSION; GENETIC POLYMORPHISM; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INTESTINE FLORA; INTESTINE INNERVATION; IRRITABLE COLON; MENOPAUSE; MENSTRUAL CYCLE; MENTAL DISEASE; META ANALYSIS (TOPIC); NONHUMAN; OVARIECTOMY; PREGNANCY; PREVALENCE; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STRESS; SYMPTOMATOLOGY; ANIMAL; FEMALE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INNERVATION; INTESTINE; IRRITABLE BOWEL SYNDROME; MALE; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; COMORBIDITY; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTESTINES; IRRITABLE BOWEL SYNDROME; MALE; MENSTRUAL CYCLE; PITUITARY-ADRENAL SYSTEM; PREVALENCE; PROGNOSIS; RISK FACTORS; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 84896822809     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i10.2433     Document Type: Article

References (163)

1. Hogan AM, Collins D, Baird AW, Winter DC. Estrogen and its role in gastrointestinal health and disease. Int J Colorectal Dis 2009; 24: 1367-1375 [PMID: 19655153 DOI: 10.1007/ s00384-009-0785-0]
2. Ji Y, Tang B, Traub RJ. The visceromotor response to colorectal distention fluctuates with the estrous cycle in rats. Neuroscience 2008; 154: 1562-1567 [PMID: 18550290 DOI: 10.1016/j.neuroscience.2008.04.070]
3. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491 [PMID: 16678561]
4. Heitkemper MM, Chang L. Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend Med 2009; 6 Suppl 2: 152-167 [PMID: 19406367 DOI: 10.1016/j.genm.2009.03.004]
5. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 2009; 10: 447-485 [PMID: 19411059 DOI: 10.1016/j.jpain.2008.12.001]
6. Larauche M, Mulak A, Taché Y. Stress and visceral pain: from animal models to clinical therapies. Exp Neurol 2012; 233: 49-67 [PMID: 21575632 DOI: 10.1016/j.expneurol.2011.04.020]
7. Mulak A, Bonaz B. Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit 2004; 10: RA55-RA62 [PMID: 15260348]
8. Rybaczyk LA, Bashaw MJ, Pathak DR, Moody SM, Gilders RM, Holzschu DL. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Womens Health 2005; 5: 12 [PMID: 16368009]
9. Taché Y, Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest 2007; 117: 33-40 [PMID: 17200704]
10. Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009; 104: 392-400 [PMID: 19174797 DOI: 10.1038/ajg.2008.94]
11. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009; 6: 306-314 [PMID: 19404271 DOI: 10.1038/nrgastro.2009.35]
12. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012; 13: 701-712 [PMID: 22968153 DOI: 10.1038/ nrn3346]
13. Heitkemper M, Jarrett M, Bond EF, Chang L. Impact of sex and gender on irritable bowel syndrome. Biol Res Nurs 2003; 5: 56-65 [PMID: 12886671]
14. Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig Dis Sci 1993; 38: 1581-1589 [PMID: 8359067]
15. Toner BB, Akman D. Gender role and irritable bowel syndrome: literature review and hypothesis. Am J Gastroenterol 2000; 95: 11-16 [PMID: 10638553]
16. Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol 2009; 24: 1601-1607 [PMID: 19788601 DOI: 10.1111/j.1440-1746.2009.05984.x]
17. Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 991-1000 [PMID: 22613905 DOI: 10.1038/ajg.2012.131]
18. Husain N, Chaudhry IB, Jafri F, Niaz SK, Tomenson B, Creed F. A population-based study of irritable bowel syndrome in a non-Western population. Neurogastroenterol Motil 2008; 20: 1022-1029 [PMID: 18492027 DOI: 10.1111/ j.1365-2982.2008.01143.x]
19. Adeyemo MA, Spiegel BM, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther 2010; 32: 738-755 [PMID: 20662786 DOI: 10.1111/j.1365-2036.2010.04409.x]
20. Heitkemper MM, Jarrett ME. Update on irritable bowel syndrome and gender differences. Nutr Clin Pract 2008; 23: 275-283 [PMID: 18595860 DOI: 10.1177/0884533608318672]
21. Chang L, Toner BB, Fukudo S, Guthrie E, Locke GR, Norton NJ, Sperber AD. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1435-1446 [PMID: 16678557]
22. Meier R, Beglinger C, Dederding JP, Meyer-Wyss B, Fumagalli M, Rowedder A, Turberg Y, Brignoli R. Influence of age, gender, hormonal status and smoking habits on colonic transit time. Neurogastroenterol Motil 1995; 7: 235-238 [PMID: 8574912]
23. Lampe JW, Fredstrom SB, Slavin JL, Potter JD. Sex differences in colonic function: a randomised trial. Gut 1993; 34: 531-536 [PMID: 8387940]
24. Tang YR, Yang WW, Wang YL, Lin L. Sex differences in the symptoms and psychological factors that influence quality of life in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2012; 24: 702-707 [PMID: 22382707 DOI: 10.1097/MEG.0b013e328351b2c2]
25. Faresjö A, Johansson S, Faresjö T, Roos S, Hallert C. Sex differences in dietary coping with gastrointestinal symptoms. Eur J Gastroenterol Hepatol 2010; 22: 327-333 [PMID: 19550348 DOI: 10.1097/MEG.0b013e32832b9c53]
26. Cain KC, Jarrett ME, Burr RL, Rosen S, Hertig VL, Heitkemper MM. Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome. Dig Dis Sci 2009; 54: 1542-1549 [PMID: 18979200]
27. Mulak A, Waszczuk E, Paradowski L. Irritable bowel syndrome as an interdisciplinary clinical problem. Adv Clin Exp Med 2008; 17: 667-675
28. Warnock JK, Clayton AH. Chronic episodic disorders in women. Psychiatr Clin North Am 2003; 26: 725-740 [PMID: 14563106]
29. Heitkemper M, Jarrett M. Irritable bowel syndrome: does gender matter? J Psychosom Res 2008; 64: 583-587 [PMID: 18501258 DOI: 10.1016/j.jpsychores.2008.02.020]
30. Palsson OS, Drossman DA. Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. Gastroenterol Clin North Am 2005; 34: 281-303 [PMID: 15862936]
31. Surdea-Blaga T, Bǎban A, Dumitrascu DL. Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol 2012; 18: 616-626 [PMID: 22363132 DOI: 10.3748/wjg. v18.i7.616]
32. García Rodríguez LA, Ruigómez A, Wallander MA, Johans-son S, Olbe L. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 2000; 35: 306-311 [PMID: 10766326]
33. Farage MA, Neill S, MacLean AB. Physiological changes associated with the menstrual cycle: a review. Obstet Gynecol Surv 2009; 64: 58-72 [PMID: 19099613 DOI: 10.1097/ OGX.0b013e3181932a37]
34. Moore J, Barlow D, Jewell D, Kennedy S. Do gastrointestinal symptoms vary with the menstrual cycle? Br J Obstet Gynaecol 1998; 105: 1322-1325 [PMID: 9883927]
35. Chang L, Lee OY, Naliboff B, Schmulson M, Mayer EA. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol 2001; 96: 3341-3347 [PMID: 11774947]
36. Mulak A, Taché Y. Sex difference in irritable bowel syndrome: do gonadal hormones play a role? Gastroenterol Pol 2010; 17: 89-97
37. Whitehead WE, Cheskin LJ, Heller BR, Robinson JC, Crowell MD, Benjamin C, Schuster MM. Evidence for exacerbation of irritable bowel syndrome during menses. Gastroenterology 1990; 98: 1485-1489 [PMID: 2338190]
38. Houghton LA, Lea R, Jackson N, Whorwell PJ. The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut 2002; 50: 471-474 [PMID: 11889064]
39. Gustafsson JK, Greenwood-Van Meerveld B. Amygdala activation by corticosterone alters visceral and somatic pain in cycling female rats. Am J Physiol Gastrointest Liver Physiol 2011; 300: G1080-G1085 [PMID: 21454447 DOI: 10.1152/ajpgi. 00349.2010]
40. Ouyang A, Wrzos HF. Contribution of gender to pathophysiology and clinical presentation of IBS: should management be different in women? Am J Gastroenterol 2006; 101: S602-S609 [PMID: 17177863]
41. Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol 1998; 93: 1867-1872 [PMID: 9772046]
42. Altman G, Cain KC, Motzer S, Jarrett M, Burr R, Heitkemper M. Increased symptoms in female IBS patients with dysmenorrhea and PMS. Gastroenterol Nurs 2006; 29: 4-11 [PMID: 16552294]
43. Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Björnsson E, Thjodleifsson B. Natural history of irritable bowel syndrome in women and dysmenorrhea: a 10-year follow-up study. Gastroenterol Res Pract 2012; 2012: 534204 [PMID: 22474441 DOI: 10.1155/2012/534204]
44. Meurs-Szojda MM, Mijatovic V, Felt-Bersma RJ, Hompes PG. Irritable bowel syndrome and chronic constipation in patients with endometriosis. Colorectal Dis 2011; 13: 67-71 [PMID: 19832874 DOI: 10.1111/j.1463-1318.2009.02055.x]
45. Mathur R, Ko A, Hwang LJ, Low K, Azziz R, Pimentel M. Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome. Dig Dis Sci 2010; 55: 1085-1089 [PMID: 19697132 DOI: 10.1007/s10620-009-0890-5]
46. Karagiannides I, Pothoulakis C. Neuropeptides, mesenteric fat, and intestinal inflammation. Ann N Y Acad Sci 2008; 1144: 127-135 [PMID: 19076372 DOI: 10.1196/annals. 1418.009]
47. Sverrisdóttir YB, Mogren T, Kataoka J, Janson PO, Stener-Victorin E. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab 2008; 294: E576-E581 [PMID: 18198350 DOI: 10.1152/ajpendo.00725.2007]
48. Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gutmicrobe communication in health and disease. Front Physiol 2011; 2: 94 [PMID: 22162969 DOI: 10.3389/fphys.2011.00094]
49. Cogan R, Spinnato JA. Pain and discomfort thresholds in late pregnancy. Pain 1986; 27: 63-68 [PMID: 3785964]
50. Gintzler AR. Endorphin-mediated increases in pain threshold during pregnancy. Science 1980; 210: 193-195 [PMID: 7414330]
51. Chiloiro M, Darconza G, Piccioli E, De Carne M, Clemente C, Riezzo G. Gastric emptying and orocecal transit time in pregnancy. J Gastroenterol 2001; 36: 538-543 [PMID: 11519832]
52. Jarrett M, Heitkemper M, Cain KC, Tuftin M, Walker EA, Bond EF, Levy RL. The relationship between psychological distress and gastrointestinal symptoms in women with irritable bowel syndrome. Nurs Res 1998; 47: 154-161 [PMID: 9610649]
53. Triadafilopoulos G, Finlayson M, Grellet C. Bowel dysfunction in postmenopausal women. Women Health 1998; 27: 55-66 [PMID: 9796084]
54. Gonenne J, Esfandyari T, Camilleri M, Burton DD, Stephens DA, Baxter KL, Zinsmeister AR, Bharucha AE. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil 2006; 18: 911-918 [PMID: 16961694]
55. Heitkemper MM, Cain KC, Jarrett ME, Burr RL, Hertig V, Bond EF. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Am J Gastroenterol 2003; 98: 420-430 [PMID: 12591063]
56. Bird ST, Liu W, Brophy JM, Bressler B, Delaney JA, Etminan M. Irritable bowel syndrome and drospirenone-containing oral contraceptives; a comparative-safety study. Curr Drug Saf 2012; 7: 8-15 [PMID: 22663950]
57. Palomba S, Orio F, Manguso F, Russo T, Falbo A, Lombardi G, Doldo P, Zullo F. Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. Fertil Steril 2005; 83: 1012-1020 [PMID: 15820814]
58. Ruigómez A, García Rodríguez LA, Johansson S, Wallander MA. Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome? Maturitas 2003; 44: 133-140 [PMID: 12590009]
59. Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004; 126: 1665-1673 [PMID: 15188159]
60. Sperber AD, Morris CB, Greemberg L, Bangdiwala SI, Goldstein D, Sheiner E, Rusabrov Y, Hu Y, Katz M, Freud T, Neville A, Drossman DA. Development of abdominal pain and IBS following gynecological surgery: a prospective, controlled study. Gastroenterology 2008; 134: 75-84 [PMID: 18166349 DOI: 10.1053/j.gastro.2007.10.041]
61. Sanoja R, Cervero F. Estrogen-dependent abdominal hyperalgesia induced by ovariectomy in adult mice: a model of functional abdominal pain. Pain 2005; 118: 243-253 [PMID: 16202534]
62. Sanoja R, Cervero F. Estrogen modulation of ovariectomyinduced hyperalgesia in adult mice. Eur J Pain 2008; 12: 573-581 [PMID: 17959401]
63. Ji Y, Murphy AZ, Traub RJ. Estrogen modulates the visceromotor reflex and responses of spinal dorsal horn neurons to colorectal stimulation in the rat. J Neurosci 2003; 23: 3908-3915 [PMID: 12736360]
64. Bradesi S, Eutamene H, Garcia-Villar R, Fioramonti J, Bueno L. Stress-induced visceral hypersensitivity in female rats is estrogen-dependent and involves tachykinin NK1 receptors. Pain 2003; 102: 227-234 [PMID: 12670663]
65. Taché Y, Million M, Nelson AG, Lamy C, Wang L. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents. Gend Med 2005; 2: 146-154 [PMID: 16290887]
66. Houghton LA, Jackson NA, Whorwell PJ, Morris J. Do male sex hormones protect from irritable bowel syndrome? Am J Gastroenterol 2000; 95: 2296-2300 [PMID: 11007231]
67. Aloisi AM. Gonadal hormones and sex differences in pain reactivity. Clin J Pain 2003; 19: 168-174 [PMID: 12792555]
68. Cairns BE, Gazerani P. Sex-related differences in pain. Maturitas 2009; 63: 292-296 [PMID: 19595525]
69. Vodo S, Bechi N, Petroni A, Muscoli C, Aloisi AM. Testosterone-induced effects on lipids and inflammation. Mediators Inflamm 2013; 2013: 183041 [PMID: 23606790 DOI: 10.1155/2013/183041]
70. Kim BJ, Rhee PL, Park JH, Chang DK, Kim YH, Son HJ, Kim JJ, Rhee JC, Lee H. Male sex hormones may influence the symptoms of irritable bowel syndrome in young men. Digestion 2008; 78: 88-92 [PMID: 18974649 DOI: 10.1159/000166600]
71. Miller V, Whitaker K, Morris JA, Whorwell PJ. Gender and irritable bowel syndrome: the male connection. J Clin Gastroenterol 2004; 38: 558-560 [PMID: 15232357]
72. Aloisi AM, Bachiocco V, Costantino A, Stefani R, Ceccarelli I, Bertaccini A, Meriggiola MC. Cross-sex hormone administration changes pain in transsexual women and men. Pain 2007; 132 Suppl 1: S60-S67 [PMID: 17379410]
73. Ter Horst GJ, Wichmann R, Gerrits M, Westenbroek C, Lin Y. Sex differences in stress responses: focus on ovarian hormones. Physiol Behav 2009; 97: 239-249 [PMID: 19275910 DOI: 10.1016/j.physbeh.2009.02.036]
74. Sinchak K, Wagner EJ. Estradiol signaling in the regulation of reproduction and energy balance. Front Neuroendocrinol 2012; 33: 342-363 [PMID: 22981653 DOI: 10.1016/ j.yfrne.2012.08.004]
75. Gintzler AR, Liu NJ. Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors. Front Neuroendocrinol 2012; 33: 412-424 [PMID: 23036438 DOI: 10.1016/j.yfrne.2012.09.004]
76. Wierman ME. Sex steroid effects at target tissues: mechanisms of action. Adv Physiol Educ 2007; 31: 26-33 [PMID: 17327579]
77. Pfaffl MW, Lange IG, Meyer HH. The gastrointestinal tract as target of steroid hormone action: quantification of steroid receptor mRNA expression (AR, ERalpha, ERbeta and PR) in 10 bovine gastrointestinal tract compartments by kinetic RT-PCR. J Steroid Biochem Mol Biol 2003; 84: 159-166 [PMID: 12710999]
78. Naliboff BD, Berman S, Chang L, Derbyshire SW, Suyenobu B, Vogt BA, Mandelkern M, Mayer EA. Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology 2003; 124: 1738-1747 [PMID: 12806606]
79. Labus JS, Gupta A, Coveleskie K, Tillisch K, Kilpatrick L, Jarcho J, Feier N, Bueller J, Stains J, Smith S, Suyenobu B, Naliboff B, Mayer EA. Sex differences in emotion-related cognitive processes in irritable bowel syndrome and healthy control subjects. Pain 2013; 154: 2088-2099 [PMID: 23791896 DOI: 10.1016/j.pain.2013.06.024]
80. McEwen BS, Akama KT, Spencer-Segal JL, Milner TA, Waters EM. Estrogen effects on the brain: actions beyond the hypothalamus via novel mechanisms. Behav Neurosci 2012; 126: 4-16 [PMID: 22289042 DOI: 10.1037/a0026708]
81. Kelly MJ, Rønnekleiv OK. A selective membrane estrogen receptor agonist maintains autonomic functions in hypoestrogenic states. Brain Res 2013; 1514: 75-82 [PMID: 23535448 DOI: 10.1016/j.brainres.2013.03.020]
82. Scharfman HE, MacLusky NJ. Differential regulation of BDNF, synaptic plasticity and sprouting in the hippocampal mossy fiber pathway of male and female rats. Neuropharmacology 2014; 76 Pt C: 696-708 [PMID: 23660230]
83. Chen XN, Zhu H, Meng QY, Zhou JN. Estrogen receptor-alpha and-beta regulate the human corticotropinreleasing hormone gene through similar pathways. Brain Res 2008; 1223: 1-10 [PMID: 18597742 DOI: 10.1016/ j.brainres.2008.05.043]
84. Kajantie E, Phillips DI. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 2006; 31: 151-178 [PMID: 16139959]
85. Larauche M, Gourcerol G, Wang L, Pambukchian K, Brunnhuber S, Adelson DW, Rivier J, Million M, Taché Y. Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways. Am J Physiol Gastrointest Liver Physiol 2009; 297: G215-G227 [PMID: 19407218 DOI: 10.1152/ajpgi.00072.2009]
86. Yuan PQ, Wu SV, Elliott J, Anton PA, Chatzaki E, Million M, Taché Y. Expression of corticotropin releasing factor receptor type 1 (CRF1) in the human gastrointestinal tract and upregulation in the colonic mucosa in patients with ulcerative colitis. Peptides 2012; 38:62-69 [PMID: 22948128 DOI: 10.1016/j.peptides.2012.07.028]
87. Bao AM, Hestiantoro A, Van Someren EJ, Swaab DF, Zhou JN. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 2005; 128: 1301-1313 [PMID: 15705605]
88. Peiffer A, Lapointe B, Barden N. Hormonal regulation of type II glucocorticoid receptor messenger ribonucleic acid in rat brain. Endocrinology 1991; 129: 2166-2174 [PMID: 1915097]
89. Goldstein JM, Jerram M, Abbs B, Whitfield-Gabrieli S, Makris N. Sex differences in stress response circuitry activation dependent on female hormonal cycle. J Neurosci 2010; 30: 431-438 [PMID: 20071507 DOI: 10.1523/JNEUROSCI. 3021-09.2010]
90. Shansky RM, Morrison JH. Stress-induced dendritic remodeling in the medial prefrontal cortex: effects of circuit, hormones and rest. Brain Res 2009; 1293: 108-113 [PMID: 19361488 DOI: 10.1016/j.brainres.2009.03.062]
91. Myers B, Schulkin J, Greenwood-Van Meerveld B. Sex steroids localized to the amygdala increase pain responses to visceral stimulation in rats. J Pain 2011; 12: 486-494 [PMID: 21167789 DOI: 10.1016/j.jpain.2010.10.007]
92. Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 2011; 140: 91-100 [PMID: 20696168 DOI: 10.1053/j.gastro.2010.07.053]
93. Videlock EJ, Adeyemo M, Licudine A, Hirano M, Ohning G, Mayer M, Mayer EA, Chang L. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology 2009; 137: 1954-1962 [PMID: 19737564 DOI: 10.1053/ j.gastro.2009.08.058]
94. Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD, Ameen VZ, Mayer EA. Dysregulation of the hypothalamic-pituitaryadrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 2009; 21: 149-159 [PMID: 18684212 DOI: 10.1111/j.1365-2982.2008.01171.x]
95. Chaloner A, Greenwood-Van Meerveld B. Sexually dimorphic effects of unpredictable early life adversity on visceral pain behavior in a rodent model. J Pain 2013; 14: 270-280 [PMID: 23348370 DOI: 10.1016/j.jpain.2012.11.008]
96. Gupta S, McCarson KE, Welch KM, Berman NE. Mechanisms of pain modulation by sex hormones in migraine. Headache 2011; 51: 905-922 [PMID: 21631476 DOI: 10.1111/ j.1526-4610.2011.01908.x]
97. Linthorst AC. Interactions between corticotropin-releasing hormone and serotonin: implications for the aetiology and treatment of anxiety disorders. Handb Exp Pharmacol 2005; (169): 181-204 [PMID: 16594259]
98. Niesler B, Kapeller J, Fell C, Atkinson W, Möller D, Fischer C, Whorwell P, Houghton LA. 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene and irritable bowel syndrome: effect of bowel habit and sex. Eur J Gas-troenterol Hepatol 2010; 22: 856-861 [PMID: 19561511 DOI: 10.1097/MEG.0b013e32832e9d6b]
99. Mizuno T, Aoki M, Shimada Y, Inoue M, Nakaya K, Takahashi T, Itoyama Y, Kanazawa M, Utsumi A, Endo Y, Nomura T, Hiratsuka M, Mizugaki M, Goto J, Hongo M, Fukudo S. Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. J Psychosom Res 2006; 60: 91-97 [PMID: 16380315]
100. Ji Y, Tang B, Traub RJ. Modulatory effects of estrogen and progesterone on colorectal hyperalgesia in the rat. Pain 2005; 117: 433-442 [PMID: 16154701]
101. Wang M. Neurosteroids and GABA-A Receptor Function. Front Endocrinol (Lausanne) 2011; 2: 44 [PMID: 22654809 DOI: 10.3389/fendo.2011.00044]
102. Pasquali R. The hypothalamic-pituitary-adrenal axis and sex hormones in chronic stress and obesity: pathophysiological and clinical aspects. Ann N Y Acad Sci 2012; 1264: 20-35 [PMID: 22612409 DOI: 10.1111/j.1749-6632.2012.06569.x]
103. Viau V, Meaney MJ. The inhibitory effect of testosterone on hypothalamic-pituitary-adrenal responses to stress is mediated by the medial preoptic area. J Neurosci 1996; 16: 1866-1876 [PMID: 8774455]
104. Chaban V. Estrogen and Visceral Nociception at the Level of Primary Sensory Neurons. Pain Res Treat 2012; 2012: [PMID: 21984961]
105. Amandusson A, Hermanson O, Blomqvist A. Colocalization of oestrogen receptor immunoreactivity and preproenkephalin mRNA expression to neurons in the superficial laminae of the spinal and medullary dorsal horn of rats. Eur J Neurosci 1996; 8: 2440-2445 [PMID: 8950107]
106. Peng HY, Chen GD, Lai CY, Hsieh MC, Hsu HH, Wu HC, Lin TB. PI3K modulates estrogen-dependent facilitation of colon-to-urethra cross-organ reflex sensitization in ovariectomized female rats. J Neurochem 2010; 113: 54-66 [PMID: 20067569 DOI: 10.1111/j.1471-4159.2010.06577.x]
107. Cheng P, Shih W, Alberto M, Presson AP, Licudine A, Mayer EA, Naliboff BD, Chang L. Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of disease. Neurogastroenterol Motil 2013; 25: e650-e659 [PMID: 23822743 DOI: 10.1111/ nmo.12177]
108. Tillisch K, Mayer EA, Labus JS, Stains J, Chang L, Naliboff BD. Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut 2005; 54: 1396-1401 [PMID: 15923667]
109. Matsumoto T, Ushiroyama T, Morimura M, Moritani T, Hayashi T, Suzuki T, Tatsumi N. Autonomic nervous system activity in the late luteal phase of eumenorrheic women with premenstrual symptomatology. J Psychosom Obstet Gynaecol 2006; 27: 131-139 [PMID: 17214447]
110. Rydlewska A, Maj J, Katkowski B, Biel B, Ponikowska B, Banasiak W, Ponikowski P, Jankowska EA. Circulating testosterone and estradiol, autonomic balance and baroreflex sensitivity in middle-aged and elderly men with heart failure. Aging Male 2013; 16: 58-66 [PMID: 23581721 DOI: 10.3109/13685538.2013.768979]
111. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-1988 [PMID: 19457422 DOI: 10.1053/j.gastro.2009.02.074]
112. Ong TS. Biomechanical properties of the Ong capsular lens and results of four years of clinical experience. J Am Intraocul Implant Soc 1984; 10: 44-48 [PMID: 6706815]
113. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007; 28: 521-574 [PMID: 17640948]
114. Gué M, Del Rio-Lacheze C, Eutamene H, Théodorou V, Fioramonti J, Buéno L. Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil 1997; 9: 271-279 [PMID: 9430796]
115. Larauche M. Novel insights in the role of peripheral corticotropin-releasing factor and mast cells in stress-induced visceral hypersensitivity. Neurogastroenterol Motil 2012; 24: 201-205 [PMID: 22316289 DOI: 10.1111/j.1365-2982.2011.01867.x]
116. Zierau O, Zenclussen AC, Jensen F. Role of female sex hormones, estradiol and progesterone, in mast cell behavior. Front Immunol 2012; 3: 169 [PMID: 22723800 DOI: 10.3389/ fimmu.2012.00169]
117. Barbara G, Stanghellini V, De Giorgio R, Corinaldesi R. Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil 2006; 18: 6-17 [PMID: 16371078]
118. Vliagoftis H, Dimitriadou V, Boucher W, Rozniecki JJ, Correia I, Raam S, Theoharides TC. Estradiol augments while tamoxifen inhibits rat mast cell secretion. Int Arch Allergy Immunol 1992; 98: 398-409 [PMID: 1384869]
119. Houghton LA, Brown H, Atkinson W, Morris J, Fell C, Whorwell PJ, Lockhart S, Keevil B. 5-hydroxytryptamine signalling in irritable bowel syndrome with diarrhoea: effects of gender and menstrual status. Aliment Pharmacol Ther 2009; 30: 919-929 [PMID: 19691669 DOI: 10.1111/ j.1365-2036.2009.04121.x]
120. Li TJ, Yu BP, Dong WG, Luo HS, Xu L, Li MQ. Ovarian hormone modulates 5-hydroxytryptamine 3 receptors mRNA expression in rat colon with restraint stress-induced bowel dysfunction. World J Gastroenterol 2004; 10: 2723-2726 [PMID: 15309727]
121. Galligan JJ, Patel BA, Schneider SP, Wang H, Zhao H, Novotny M, Bian X, Kabeer R, Fried D, Swain GM. Visceral hypersensitivity in female but not in male serotonin transporter knockout rats. Neurogastroenterol Motil 2013; 25: e373-e381 [PMID: 23594365 DOI: 10.1111/nmo.12133]
122. Franke L, Schmidtmann M, Riedl A, van der Voort I, Uebelhack R, Mönnikes H. Serotonin transporter activity and serotonin concentration in platelets of patients with irritable bowel syndrome: effect of gender. J Gastroenterol 2010; 45: 389-398 [PMID: 19997855 DOI: 10.1007/s00535-009-0167-y]
123. Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009; 58: 196-201 [PMID: 18824556 DOI: 10.1136/gut.2007.140806]
124. Braniste V, Leveque M, Buisson-Brenac C, Bueno L, Fioramonti J, Houdeau E. Oestradiol decreases colonic permeability through oestrogen receptor beta-mediated upregulation of occludin and junctional adhesion molecule-A in epithelial cells. J Physiol 2009; 587: 3317-3328 [PMID: 19433574 DOI: 10.1113/jphysiol.2009.169300]
125. Houdeau E, Moriez R, Leveque M, Salvador-Cartier C, Waget A, Leng L, Bueno L, Bucala R, Fioramonti J. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat. Gastroenterology 2007; 132: 982-993 [PMID: 17324399]
126. Verdú EF, Deng Y, Bercik P, Collins SM. Modulatory effects of estrogen in two murine models of experimental colitis. Am J Physiol Gastrointest Liver Physiol 2002; 283: G27-G36 [PMID: 12065288]
127. Alonso C, Guilarte M, Vicario M, Ramos L, Rezzi S, Martínez C, Lobo B, Martin FP, Pigrau M, González-Castro AM, Gallart M, Malagelada JR, Azpiroz F, Kochhar S, Santos J. Acute experimental stress evokes a differential gender-determined increase in human intestinal macromolecular permeability. Neurogastroenterol Motil 2012; 24: 740-746; e348-e349 [PMID: 22625665 DOI: 10.1111/ j.1365-2982.2012.01928.x]
128. Levin ER. Membrane oestrogen receptor alpha signalling to cell functions. J Physiol 2009; 587: 5019-5023 [PMID: 19687123 DOI: 10.1113/jphysiol.2009.177097]
129. Kawano N, Koji T, Hishikawa Y, Murase K, Murata I, Kohno S. Identification and localization of estrogen receptor alpha-and beta-positive cells in adult male and female mouse intestine at various estrogen levels. Histochem Cell Biol 2004; 121: 399-405 [PMID: 15138841]
130. Cong P, Pricolo V, Biancani P, Behar J. Abnormalities of prostaglandins and cyclooxygenase enzymes in female patients with slow-transit constipation. Gastroenterology 2007; 133: 445-453 [PMID: 17681165]
131. Vasiadi M, Kempuraj D, Boucher W, Kalogeromitros D, Theoharides TC. Progesterone inhibits mast cell secretion. Int J Immunopathol Pharmacol 2006; 19: 787-794 [PMID: 17166400]
132. García-Gómez E, González-Pedrajo B, Camacho-Arroyo I. Role of sex steroid hormones in bacterial-host interactions. Biomed Res Int 2013; 2013: 928290 [PMID: 23509808 DOI: 10.1155/2013/928290]
133. Su L, Sun Y, Ma F, Lü P, Huang H, Zhou J. Progesterone inhibits Toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-kappaB activation and enhancing SOCS1 expression. Immunol Lett 2009; 125: 151-155 [PMID: 19607861 DOI: 10.1016/j.imlet.2009.07.003]
134. González-Montelongo MC, Marín R, Gómez T, Marrero-Alonso J, Díaz M. Androgens induce nongenomic stimulation of colonic contractile activity through induction of calcium sensitization and phosphorylation of LC20 and CPI-17. Mol Endocrinol 2010; 24: 1007-1023 [PMID: 20207835 DOI: 10.1210/me.2009-0472]
135. Aloisi AM, Affaitati G, Ceccarelli I, Fiorenzani P, Lerza R, Rossi C, Pace MC, Chiefari M, Aurilio C, Giamberardino MA. Estradiol and testosterone differently affect visceral pain-related behavioural responses in male and female rats. Eur J Pain 2010; 14: 602-607 [PMID: 19948419 DOI: 10.1016/ j.ejpain.2009.10.016]
136. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004; 361: 184-187 [PMID: 15135924]
137. Chen W, Beck I, Schober W, Brockow K, Effner R, Buters JT, Behrendt H, Ring J. Human mast cells express androgen receptors but treatment with testosterone exerts no influence on IgE-independent mast cell degranulation elicited by neuromuscular blocking agents. Exp Dermatol 2010; 19: 302-304 [PMID: 19758318 DOI: 10.1111/j.1600-0625.2009.00969.x]
138. Rettew JA, Huet-Hudson YM, Marriott I. Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reprod 2008; 78: 432-437 [PMID: 18003947]
139. Dinan TG, Cryan JF. Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology 2012; 37: 1369-1378 [PMID: 22483040 DOI: 10.1016/j.psyneuen.2012.03.007]
140. Dinan TG, Cryan JF. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil 2013; 25: 713-719 [PMID: 23910373 DOI: 10.1111/nmo.12198]
141. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2013; 18: 666-673 [PMID: 22688187 DOI: 10.1038/mp.2012.77]
142. Kornman KS, Loesche WJ. Effects of estradiol and progesterone on Bacteroides melaninogenicus and Bacteroides gingivalis. Infect Immun 1982; 35: 256-263 [PMID: 6119293]
143. Menon R, Watson SE, Thomas LN, Allred CD, Dabney A, Azcarate-Peril MA, Sturino JM. Diet complexity and estrogen receptor β status affect the composition of the murine intestinal microbiota. Appl Environ Microbiol 2013; 79: 5763-5773 [PMID: 23872567 DOI: 10.1128/AEM.01182-13]
144. Adlercreutz H, Pulkkinen MO, Hämäläinen EK, Korpela JT. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones. J Steroid Biochem 1984; 20: 217-229 [PMID: 6231418]
145. Raftogianis R, Creveling C, Weinshilboum R, Weisz J. Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr 2000; (27): 113-124 [PMID: 10963623]
146. Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, Gajer P, Ravel J, Goedert JJ. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med 2012; 10: 253 [PMID: 23259758 DOI: 10.1186/1479-5876-10-253]
147. Lombardi P, Goldin B, Boutin E, Gorbach SL. Metabolism of androgens and estrogens by human fecal microorganisms. J Steroid Biochem 1978; 9: 795-801 [PMID: 713557]
148. Donova MV, Egorova OV. Microbial steroid transformations: current state and prospects. Appl Microbiol Biotechnol 2012; 94: 1423-1447 [PMID: 22562163 DOI: 10.1007/ s00253-012-4078-0]
149. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013; 339: 1084-1088 [PMID: 23328391 DOI: 10.1126/science.1233521]
150. Flak MB, Neves JF, Blumberg RS. Immunology. Welcome to the microgenderome. Science 2013; 339: 1044-1045 [PMID: 23449586 DOI: 10.1126/science.1236226]
151. Koch KM, Palmer JL, Noordin N, Tomlinson JJ, Baidoo C. Sex and age differences in the pharmacokinetics of alosetron. Br J Clin Pharmacol 2002; 53: 238-242 [PMID: 11874386]
152. Voß U, Lewerenz A, Nieber K. Treatment of irritable bowel syndrome: sex and gender specific aspects. Handb Exp Pharmacol 2012; (214): 473-497 [PMID: 23027463 DOI: 10.1007/97 8-3-642-30726-3_21]
153. Nakai A, Diksic M, Kumakura Y, D'Souza D, Kersey K. The effects of the 5-HT3 antagonist, alosetron, on brain serotonin synthesis in patients with irritable bowel syndrome. Neurogastroenterol Motil 2005; 17: 212-221 [PMID: 15787942]
154. Kano M, Mizuno T, Kawano Y, Aoki M, Kanazawa M, Fukudo S. Serotonin transporter gene promoter polymorphism and alexithymia. Neuropsychobiology 2012; 65: 76-82 [PMID: 22222552]
155. Monostory K, Dvorak Z. Steroid regulation of drug-metabolizing cytochromes P450. Curr Drug Metab 2011; 12: 154-172 [PMID: 21395541]
156. Creed F, Fernandes L, Guthrie E, Palmer S, Ratcliffe J, Read N, Rigby C, Thompson D, Tomenson B. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003; 124: 303-317 [PMID: 12557136]
157. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritablebowel syndrome. Lancet 1984; 2: 1232-1234 [PMID: 6150275]
158. Moser G, Trägner S, Gajowniczek EE, Mikulits A, Michalski M, Kazemi-Shirazi L, Kulnigg-Dabsch S, Führer M, Ponocny-Seliger E, Dejaco C, Miehsler W. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2013; 108: 602-609 [PMID: 23419384 DOI: 10.1038/ajg.2013.19]
159. Brennan MJ. The effect of opioid therapy on endocrine function. Am J Med 2013; 126: S12-S18 [PMID: 23414717 DOI: 10.1016/j.amjmed.2012.12.001]
160. Vodo S, Arcelli D, Fiorenzani P, Meriggiola MC, Butkevich I, Di Canio C, Mikhailenko V, Aloisi AM. Gonadal ERα/ β, AR and TRPV1 gene expression: modulation by pain and morphine treatment in male and female rats. Physiol Behav 2013; 110-111: 80-86 [PMID: 23287630 DOI: 10.1016/ j.physbeh.2012.12.014]
161. Saulnier DM, Ringel Y, Heyman MB, Foster JA, Bercik P, Shulman RJ, Versalovic J, Verdu EF, Dinan TG, Hecht G, Guarner F. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes 2013; 4: 17-27 [PMID: 23202796 DOI: 10.4161/gmic.22973]
162. Mulak A. Good bacteria for good mood: probiotics and the brain-gut axis interactions. Pol Arch Med Wewn 2013; 123: 71-72 [PMID: 23449192]
163. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128: 541-551 [PMID: 15765388]